The DIA Annual Meeting is designed for the full continuum of disciplines in the pharmaceutical and related industries to improve biotechnology, pharmaceutical, and regulatory professionals' understanding and skills as related to issues and solutions for a variety of pharmaceutical development interest areas. The meeting offers attendees valuable professional cross-functional learning, networking experiences, and continuing education credits.

WilmerHale Partner Scott Lassman will be a featured speaker at this years' event. He will speak on the topic of "Preparing for FDAAA Implementation: An Overview of FDAAA Safety Provisions," on June 25.